UK MHRA (Medicines and Healthcare products Regulatory Agency) warns on device maintenance
This article was originally published in Clinica
The issue of device maintenance frequency and quality-assurance have re-emerged in the UK with a warning from the Medicines and Healthcare products Regulatory Agency (MHRA) to heed manufacturer guidelines. An MHRA alert issued last week focuses on the risks of inadequate servicing of gas regulators and flowmeters.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.